Onyx is a research collective building a virtual immune system from longitudinal human immune data.
Onyx Bio has raised $8.0M in total funding. The most recent round was Seed. The last funding was announced in October 2026.
Onyx Bio's investors include Haystack, Dimension Capital, Robot Ventures, Refactor, Standard.
Onyx Bio is headquartered in Berkeley, United States.
Onyx is a research collective building a virtual immune system from longitudinal human immune data.
Onyx Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Onyx Bio — Funding & Investors." VCBacked, October 8, 2026, https://www.vcbacked.co/company/onyx-bio. Accessed November 15, 2026.
VCBacked. (2026). Onyx Bio — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/onyx-bio
{{cite web |title=Onyx Bio — Funding & Investors |url=https://www.vcbacked.co/company/onyx-bio |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Onyx Bio? Request a listing update